Riskpilot← Back to searchSign inGet full accessOVERNKLINIKKEN AS
ASActiveOrg 993955353Overnveien 340, 3340 ÅmotMedical specialists activities · NACE 8622Est. 20095 employees
Revenue 2025
NOK 7,8M
+29% vs 2024
EBITDA margin
37.2%
+150% vs 2024
Equity ratio
72.0%
Financial strength
Net profit 2025
NOK 2,4M
+174% vs 2024
| Revenue | NOK 7,8M | +29% |
| EBITDA | NOK 2,9M | +150% |
| Net profit | NOK 2,4M | +174% |
| Total assets | NOK 5,6M | -11% |
| Equity | NOK 4M | +54% |
| Employees | 5 | — |
Legal name
OVERNKLINIKKEN AS
Org number
993955353
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
16. april 2009
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Spesialisert legetjeneste, samt alt hva herved naturlig står i forbindelse.
Address
Overnveien 340, 3340 Åmot
Phone
+4732757500
Email
post@overnklinikken.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 477 | 5 799 | 5 894 | 6 048 | 7 820 |
| Staff expenses | −2 608 | −2 644 | −2 666 | −3 489 | −3 482 |
| EBITDA | 1 501 | 1 780 | 1 778 | 1 162 | 2 908 |
| Depreciation & amort. | −208 | −298 | −273 | −244 | −87 |
| EBIT | 1 292 | 1 483 | 1 505 | 918 | 2 821 |
| Net financials | 4 | 14 | 87 | 236 | 186 |
| Profit before tax | 1 297 | 1 496 | 1 592 | 1 154 | 3 007 |
| Tax | 274 | 347 | 370 | 273 | 589 |
| Net profit | 1 023 | 1 149 | 1 222 | 881 | 2 418 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 685 | 5 265 | 6 093 | 6 277 | 5 597 |
| Equity | 3 360 | 3 508 | 4 730 | 2 611 | 4 029 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 325 | 1 757 | 1 363 | 3 666 | 1 568 |
| Total debt | 1 325 | 1 757 | 1 363 | 3 666 | 1 568 |
EBITDA margin
37.2%
This company
15.8%
Market median
+135% vs market
20212025
Equity ratio
72.0%
This company
38.2%
Market median
+88% vs market
20212025
Return on equity
60.0%
This company
18.4%
Market median
+226% vs market
20212025
Net profit margin
30.9%
This company
8.1%
Market median
+281% vs market
20212025
Asset turnover
1.40×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO Deputy Member | Deputy Member | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OVERNKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arild Overn | Deputy Member | 0 companies |
| Sissel Overn | Chairman | 0 companies |